Hero Image
19 November 2020
Dublin (Online), Ireland
RCSI and Trinity Innovation Showcase 2020

VertigeniusA mobile health and wearable-sensor based exercise application for the rehabilitation of dizziness, vertigo and balance problems.

View in Marketplace

Dara Meldrum 
TCD
MedTech
InjurySenseA wearable device providing muscle injury prediction in real time using wireless sensors and a mobile app. This device is for athletes, coaches and physios. It is predictive, easy to use and convenient.

View in Marketplace 
Adam Geraghty TCDMedTech
TympanoColl A novel biomaterial to regenerate tympanic membrane perforations.

View in Marketplace
Cian O'Leary RCSIMedTech
ChemoGelChemoGel is a unique, thermoresponsive, hydrogel drug delivery platform for the site-specific delivery and sustained release of chemotherapeutics at solid tumour sites. ChemoGel is a platform technology which enables the sustained local delivery of chemotherapeutics agents and is intended for use in the chemical ablation of solid tumours alone or in conjunction with other treatment approaches.

View in Marketplace
Helena Kelly RCSIDrug Delivery

InnovoSepBreakthrough therapy in the fight against sepsis.  RCSI research has demonstrated that the drug has potential to stop all sepsis-causing bacteria from triggering endothelial dysfunction and organ damage in the early stages of the condition.

View in Marketplace
Steve Kerrigan RCSITherapeutics
iSentioLabs

iSentioLabs is a provider of innovative and market-disruptive process monitoring technology which brings new features and benefits to the industrial marketplace.

View in Marketplace 
Garret O'Donnell
TCD
Engineering
Akara Robotics Akara is a spin-out company from Trinity College Dublin and builds on over a decade of pioneering scientific research in robotics and artificial intelligence. Akara’s mission is to develop technology that empowers people in the healthcare industry.

View in Marketplace 
Conor McGinn
TCD
ICT
EmpushyEmpushy aims to develop an intelligent push-notification platform which improves the experience of both sending and receiving push-notifications.

View in Marketplace 
Kieran Fraser
TCD
ICT
E-SeedE-Seed is commercialising patented endophytes that can increase crop yields. This natural microbial treatment is applied as a coating via standard seed-dressing equipment, enriching the beneficial microbiome of the crop and improving the uptake of available nutrients.

View in Marketplace 
Sean Daly  TCD/UCDAgTech
Biologit Biologit is is an early stage technology company developing software using Artificial Intelligence for Clinical Safety & Pharmacovigilance.

View in Marketplace
Nicole Baker TCDICT
SenopticaTCD spinout company developing Oxygen-Sensitive Printable Ink Sensor Formulations as Integrity Indicators for Modified Atmosphere Packaged Foods. 

View in Marketplace

Brendan Rice 
TCD
Advanced Materials 
Pre Spin-Out/ Early Stage/ Commercialisation Fund
Papelli

Pre-spinout from TCD and UCC developing a cost effective platform technology for structural antireflective surfaces for applications in optics. 

View in Marketplace
Parvaneh Mokarian- Tabari
TCD

Advanced Materials

EasyHydroA pre-TCD campus company developing low-cost hydropower solutions for energy generation. Company is in the process of acquiring customers and increasing their installation base ahead of any seed funding.

View in Marketplace
Aonghus McNabola
TCD
Energy
Solar Cool A Solar PV research project 'SolarCool' to improve the efficiency and lifetime of solar panels. Goal is to spin out a technology company supplying solutions to the solar industry. Currently funded under the SFI Zero Emission challenge.

View in Marketplace
David McCloskey
TCD
Energy
Carbon Impact A carbon dioxide capture project 'Carbon-Impact' funded under the SFI Zero emissions challenge. Goal is to efficiently capture CO2 from the air utilising metal organic framework (MOFs).

View in Marketplace
Wolfgang Schmitt
TCD

Energy
GMERSResearch project developing a technique to identify trace element comtaminants in water. The technology utilises novel materials along with a known elemental analysis equipment (Raman Spectroscopy).

View in Marketplace
Jing Jing Wang 
TCD
Advanced Materials
Novel metal additive manufacturing

Research Project developing a new disruptive method for Powder Bed Fusion additive manufacturing to considerably improve machine materials flexibility. Goal is to develop a spinout opportunity to supply into the additive manufacturing industry.


View in Marketplace
Rocco Lupoi
TCD
Engineering
HyaGlaucHyaGlauc is a bioactive hydrogel implant to facilitate enhanced patient recovery following glaucoma filtration surgery (trabeculectomy).

View in Marketplace
Alan Hibbitts
RCSI
MedTech
PReductionPReduction is a novel medical device approach to treat Heart Failure with preserved ejection fraction.

View in Marketplace
Aamir Hameed
RCSI
MedTech
SMURFThe RCSI SMURF project (Small Molecule ManUfacture including amino acids, peptides, pRoteins and biomacromolecules for late stage inclusion of 18F and 19F) is developing new chemical methodologies for the synthesis of high-value Fluorinated APIs, tracer compounds and fine chemicals.

View in Marketplace

Mauro Adamo
RCSI
Therapeutics
StarMatStarMat is developing a unique, patented class of Star Polypeptides for RNA drug delivery, antimicrobial and biomaterial/tissue regeneration applications.

View in Marketplace

Sally-Ann Cryan
RCSI
MedTech
AIMAPIT AIMapIT constitutes an innovative AI solution for discovery, detection and GPS mapping of stationary objects. The system can be trained to detect any street furniture and minor landmarks from street level imagery 

View in Marketplace
Rozenn Dahyot
TCD
ICT
DevnosticsSoftware Development Analytics for everyone.
We dive deep into the data to tell you what you need to know.

View in Marketplace


Stephen Barrett
TCD
ICT
WaytoBIndependent travel for everyone
WaytoB is a smartphone and smartwatch solution to empower people with higher support needs to travel independently

View in Marketplace
Robbie Fryers
TCD
ICT

Caliber

Caliber Assistant is a digital publishing intelligence that flags potentially defamatory or harmful text, suggests correction and reduces the risk of publication of such material.

View in Marketplace
Neil Brady TCD





ICT
Darwin & GoliathDarwin & Goliath helps you turn visitors into loyal customers by displaying the right product at the right time 

View in Marketplace
Eamonn Donlyn
TCD
ICT
Between MachinesBetween Machines is a MusicTech developer. Its core product is STREAMER, a sequencing ecosystem for Eurorack.

View in Marketplace  
Dennis McNultyICT
ALPACA

Dyslexia Assessment using Phonics for prereading children

View in Marketplace


Jen O'Sullivan
TCD/MIE

ICT
Energy Aware IOT

Deep Q-learning method for optimisation of energy aware scheduling for IOT

View in Marketplace
Jernej Hribar
TCD

ICT
ParvalisParvalis Tx is an early stage drug discovery company in the Auto-Immune and Inflammation space founded by Dr William McCormack and Professor Kingston Mills (TCD). The company is focused on developing orally available small molecule inhibitors to pathways that have already been validated (clinically/commercially) by biologics. 

View in Marketplace
William McCormack TCD Therapeutics
DIOLSENSE:

Novel hydrogel materials which react to diols (such as lactate and glucose) for sensing applications. These can be 3D printed for bespoke applications for bio-medical applications.

View in Marketplace

Larissa Florea      TCD

Advanced Materials 
VisiokineAge-related macular degeneration is the leading cause of blindness in adults in industrialised countries. The founders of Visiokine have shown that IL-18 can slow progression of wet AMD in a variety of animal models. Visiokine now aims to progress IL-18 into clinical development to explore adjunctive efficacy with anti-VEGFs for treatment of wet AMD

View in Marketplace
Sarah Doyle,
Matthew Campbell 
TCD
Therapeutics 
PhysicianScriptsPhysicianScript is a software system for clinicians and patients that aligns symptoms, treatment use and outcomes to ensure accurate clinical decisions and reduce costs associated with chronic respiratory disease
We are focused initially on the $40Bn Asthma/COPD market.

View in Marketplace
Richard CostelloICT/MedTech

Registration
Closed since 19 November 2020
Location Online
Organised by